Gastric-Type Adenocarcinoma of the Uterine Cervix Associated with Poor Response to Definitive Radiotherapy
Authors:
- Airi KurumaAKAiri Kuruma
- Michiko KodamaMKMichiko Kodama
- Yumiko HoriYHYumiko Hori
- Kazuaki SatoKSKazuaki Sato
- Makoto FujiiMFMakoto Fujii
- Fumiaki IsohashiFIFumiaki Isohashi
- Ai MiyoshiAMAi Miyoshi
- Seiji MabuchiSMSeiji Mabuchi
- Akira SetoguchiASAkira Setoguchi
- Hiroko ShimuraHSHiroko Shimura
- Takeshi GotoTGTakeshi Goto
- Aska TodaATAska Toda
Open Access
Abstract
We aimed to evaluate the response to definitive radiotherapy (RT) for cervical cancer based on histological subtypes and investigate prognostic factors in adenocarcinoma (AC). Of the 396 patients treated with definitive RT between January, 2010 and July, 2020, 327 patients met the inclusion criteria, including 275 with squamous cell carcinoma (SCC) and 52 with AC restaged based on the 2018 International Federation of Gynecology and Obstetrics staging system. Patient characteristics, response to RT, and prognoses of SCC and AC were evaluated. The complete response (CR) rates were 92.4% and 53.8% for SCC and AC, respectively (p < 0.05). Three-year overall survival and progression-free survival (PFS) rates of SCC were significantly higher than those of AC (88.6% vs. 74.1%, p < 0.05 and 76.3% vs. 59.3%, p < 0.05, respectively). Among the AC population, univariate and multivariate analyses were performed to examine prognostic factors associated with non-complete response (CR). In the multivariate analysis, gastric-type adenocarcinoma (GAS) was associated with non-CR in AC (adjusted odds ratio, 12.2; 95% confidence interval 1.0–145.6; p < 0.05). The 3-year PFS rate in patients with GAS was significantly lower than that in patients with other histological types of AC (44.4% vs. 66.7%, p < 0.05). Definitive RT for cervical cancer was significantly less effective for AC than for SCC. GAS was the only independent prognostic factor associated with non-CR in AC.Keywords
This publication has 35 references indexed in Scilit:
- Gastric-type Endocervical AdenocarcinomaAmerican Journal of Surgical Pathology, 2015
- Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological studyInternational Journal of Cancer, 2015
- Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-based chemoradiationGynecologic Oncology, 2014
- HPV‐negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosisBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancerGynecologic Oncology, 2012
- Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapyArchives of Gynecology and Obstetrics, 2012
- Absence of High-Risk Human Papillomavirus (HPV) Detection in Endocervical Adenocarcinoma with Gastric Morphology and PhenotypeThe American Journal of Pathology, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Gastric Morphology and Immunophenotype Predict Poor Outcome in Mucinous Adenocarcinoma of the Uterine CervixAmerican Journal of Surgical Pathology, 2007
- Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000Cancer, 2004